Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 17.11.2008 |
---|---|
08:11 | First Pivotal Trials Begin for Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef(TM) (BIBF 1120) |
Zeit | Boehringer Ingelheim: Meldungen vom 17.11.2008 |
---|---|
08:11 | First Pivotal Trials Begin for Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef(TM) (BIBF 1120) |